<?xml version="1.0" encoding="UTF-8"?>
<xml><bibliography><APA>Thitirat Thapornsawat และผู้แต่งคนอื่นๆ. (2023) Incidence of adverse drug reactions in immune checkpoint inhibitors among cancer patients with cancer at a University Hospital. &lt;i&gt;Isan Journal of Pharmaceutical Sciences&lt;/i&gt;, &lt;i&gt;19&lt;/i&gt;(1), 32-41.</APA><Chicago>Thitirat Thapornsawat และผู้แต่งคนอื่นๆ. "Incidence of adverse drug reactions in immune checkpoint inhibitors among cancer patients with cancer at a University Hospital". Isan Journal of Pharmaceutical Sciences  19 (2023):32-41.</Chicago><MLA>Thitirat Thapornsawat และผู้แต่งคนอื่นๆ. Incidence of adverse drug reactions in immune checkpoint inhibitors among cancer patients with cancer at a University Hospital. Faculty of Pharmaceutical Sciences KKU MSU UBU:ม.ป.ท. 2023.</MLA></bibliography></xml>
